Magnetic Flexible Endoscope for Inflammatory Bowel Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new device called the Magnetic Flexible Endoscope (MFE) to evaluate its movement through the colon of individuals with Inflammatory Bowel Disease (IBD), such as Ulcerative Colitis or Crohn's Disease. The MFE consists of a thin tube with a camera, light, and magnet at the tip, guided through the colon by a robotic arm. The study aims to determine if the MFE is easy to use and comfortable for patients. Individuals with stable IBD who are not experiencing flare-ups might be suitable candidates for this trial. As an unphased trial, this study allows patients to contribute to innovative research that could enhance future diagnostic procedures.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you have taken anticoagulant or antiplatelet medications (except aspirin) in the last 3 days.
What prior data suggests that the Magnetic Flexible Endoscope is safe for use in patients with Inflammatory Bowel Disease?
Research has shown that the Magnetic Flexible Endoscope (MFE) has been tested in people without causing problems or discomfort. In earlier studies, the MFE moved smoothly through the colon. This endoscope is unique because a magnet at its tip is guided by another magnet on a robotic arm outside the body. This design aids its easy movement through the colon. So far, the MFE has been well-received, demonstrating promising safety results.12345
Why are researchers excited about this trial?
Researchers are excited about the Magnetic Flexible Endoscope (MFE) because it offers a new approach to examining the colon in patients with inflammatory bowel disease (IBD) and those needing colorectal cancer screening. Unlike the standard colonoscopy, which uses a rigid tube, the MFE is more flexible and uses magnetic guidance, potentially making the procedure more comfortable and less invasive for patients. This innovative method could improve visualization and access during the procedure, providing a clearer view and possibly better diagnostic accuracy. The hope is that the MFE could enhance patient experience and outcomes, making it a promising advancement in the field.
What evidence suggests that the Magnetic Flexible Endoscope is effective for Inflammatory Bowel Disease?
Research shows that the Magnetic Flexible Endoscope (MFE) holds promise for safely exploring the colon. Earlier studies found that it could navigate the colon without causing harm or discomfort. The MFE uses magnets, making it easier to guide than traditional scopes. This trial will compare two approaches: one group will undergo their standard of care (SOC) colonoscopy followed by the MFE, while the other group will have a colonoscopy with the MFE followed by the SOC colonoscopy. This new method could help detect early signs of colorectal cancer, potentially improving patient health. Although more research is needed, early results are encouraging for people with Inflammatory Bowel Disease (IBD) considering this new technique.12346
Who Is on the Research Team?
Keith L Obstein
Principal Investigator
Vanderbilt University Medical Center
Are You a Good Fit for This Trial?
This trial is for individuals with Inflammatory Bowel Disease (IBD) who are interested in a new colon examination method. Specific eligibility criteria aren't provided, but typically participants must meet certain health standards and not have conditions that could interfere with the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo colonoscopy using the Magnetic Flexible Endoscope (MFE) and standard of care colonoscopy
Follow-up
Participants are monitored for safety and tolerability after the procedure
What Are the Treatments Tested in This Trial?
Interventions
- Magnetic Flexible Endoscope (MFE)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Vanderbilt University Medical Center
Lead Sponsor
National Institute for Biomedical Imaging and Bioengineering (NIBIB)
Collaborator